BRPI0610156A2 - forma micronizada de um composto, forma purificada i do composto, kit, padrão de referência, e, método de preparaçao de uma composição farmacêutica. - Google Patents

forma micronizada de um composto, forma purificada i do composto, kit, padrão de referência, e, método de preparaçao de uma composição farmacêutica.

Info

Publication number
BRPI0610156A2
BRPI0610156A2 BRPI0610156A BRPI0610156A BRPI0610156A2 BR PI0610156 A2 BRPI0610156 A2 BR PI0610156A2 BR PI0610156 A BRPI0610156 A BR PI0610156A BR PI0610156 A BRPI0610156 A BR PI0610156A BR PI0610156 A2 BRPI0610156 A2 BR PI0610156A2
Authority
BR
Brazil
Prior art keywords
compound
kit
preparing
pharmaceutical composition
reference standard
Prior art date
Application number
BRPI0610156A
Other languages
English (en)
Inventor
Arkadiy Zinoviy Rubezhov
Arwinder Nagi
Bogdan Kazimierz Wilk
John Potoski
Jean Louise Helom
Ramarao Chtlapalli
Vladimir Dragan
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=37000404&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BRPI0610156(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Wyeth Corp filed Critical Wyeth Corp
Publication of BRPI0610156A2 publication Critical patent/BRPI0610156A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/04—1,3-Oxazines; Hydrogenated 1,3-oxazines
    • C07D265/12—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems
    • C07D265/14—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Diabetes (AREA)
  • Nutrition Science (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
BRPI0610156A 2005-04-28 2006-04-26 forma micronizada de um composto, forma purificada i do composto, kit, padrão de referência, e, método de preparaçao de uma composição farmacêutica. BRPI0610156A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US67573805P 2005-04-28 2005-04-28
PCT/US2006/015813 WO2006116498A2 (en) 2005-04-28 2006-04-26 Purified form of tanaproget

Publications (1)

Publication Number Publication Date
BRPI0610156A2 true BRPI0610156A2 (pt) 2016-08-16

Family

ID=37000404

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0610156A BRPI0610156A2 (pt) 2005-04-28 2006-04-26 forma micronizada de um composto, forma purificada i do composto, kit, padrão de referência, e, método de preparaçao de uma composição farmacêutica.

Country Status (14)

Country Link
US (1) US7786297B2 (pt)
EP (1) EP1874743B1 (pt)
JP (2) JP2008539254A (pt)
CN (1) CN101184738B (pt)
AR (1) AR053595A1 (pt)
AU (1) AU2006241189B2 (pt)
BR (1) BRPI0610156A2 (pt)
CA (1) CA2603786A1 (pt)
ES (1) ES2431324T3 (pt)
GT (1) GT200600173A (pt)
MX (1) MX2007013470A (pt)
PE (1) PE20061322A1 (pt)
TW (1) TW200716130A (pt)
WO (1) WO2006116498A2 (pt)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0610433A2 (pt) * 2005-04-28 2010-11-23 Wyeth Corp forma polimórfica ii de tanaproget, processos para preparar a mesma, e para preparar forma micronizada de um composto, composição farmacêutica, método de preparação de uma composição farmacêutica, e, uso da forma polimórfica ii de tanaproget ou da forma micronizada
SI1896034T1 (sl) 2005-04-28 2010-07-30 Wyeth Llc Mikronizirani sestavki tanaprogeta in postopki priprave le-tega
EP1877059B8 (en) 2005-04-28 2010-05-19 Wyeth a Corporation of the State of Delaware Micronized tanaproget and compostions containing same
WO2007030153A2 (en) * 2005-04-28 2007-03-15 Wyeth Compositions containing micronized tanaproget
CN103989687A (zh) 2005-06-09 2014-08-20 惠氏公司 含有炔雌醇的tanaproget组合物
BRPI0819571A2 (pt) 2007-12-20 2019-09-24 Teva Womenss Health Inc "método para contracepção de emergência, pacote farmacêutico para contracepção de emergência e composição farmacêutica"
WO2014143617A1 (en) * 2013-03-14 2014-09-18 Teva Women's Health, Inc. Deuterium-enriched tanaproget and processes for its preparation

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE386729T1 (de) * 1999-05-04 2008-03-15 Wyeth Corp Cyclothiocarbamatderivate als progesteron- rezeptormodulatoren
UA73119C2 (en) 2000-04-19 2005-06-15 American Home Products Corpoir Derivatives of cyclic thiocarbamates, pharmaceutical composition including noted derivatives of cyclic thiocarbamates and active ingredients of medicines as modulators of progesterone receptors
US7268149B2 (en) 2002-06-25 2007-09-11 Wyeth Cyclothiocarbamate derivatives as progesterone receptor modulators and methods of treating skin disorders
RU2005101638A (ru) 2002-06-25 2006-01-20 Уайт (Us) Использование циклокарбаматных производных для лечения гормонзависимых состояний
TW200604137A (en) * 2004-04-27 2006-02-01 Wyeth Corp Coupling process for generating reactive boron-containing derivatives of n-substituted pyrrole-2-carbonitriles to produce biaryls
EP1756072A2 (en) * 2004-04-27 2007-02-28 Wyeth Purification of progesterone receptor modulators
SI1778710T1 (sl) 2004-08-13 2012-05-31 Wyeth Llc Derivati tanaprogeta metaboliti in njihove uporabe

Also Published As

Publication number Publication date
AR053595A1 (es) 2007-05-09
EP1874743A2 (en) 2008-01-09
ES2431324T3 (es) 2013-11-26
AU2006241189B2 (en) 2012-01-19
EP1874743B1 (en) 2013-07-17
TW200716130A (en) 2007-05-01
CN101184738A (zh) 2008-05-21
PE20061322A1 (es) 2006-12-28
MX2007013470A (es) 2008-01-22
WO2006116498A2 (en) 2006-11-02
US20060247236A1 (en) 2006-11-02
CN101184738B (zh) 2012-05-23
GT200600173A (es) 2006-11-22
AU2006241189A1 (en) 2006-11-02
US7786297B2 (en) 2010-08-31
CA2603786A1 (en) 2006-11-02
JP2008539254A (ja) 2008-11-13
JP2013231042A (ja) 2013-11-14
WO2006116498A3 (en) 2006-12-14

Similar Documents

Publication Publication Date Title
DK1940467T3 (da) Lægemiddelsammensætning med langvarig frigivelse
BRPI0613033A2 (pt) composição oral
RU2398586C3 (ru) Фармацевтическая композиция
GB0513692D0 (en) Novel pharmaceutical compositions
IL177480A0 (en) Pharmaceutical composition
ZA200708705B (en) Pharmaceutical composition
GB0405033D0 (en) Novel pharmaceutical compositions
GB0406378D0 (en) Novel pharmaceutical compositions
SI1802275T1 (sl) Farmacevtski sestavki, ki maskirajo okus
GB0406380D0 (en) Novel pharmaceutical compositions
HU0401177D0 (en) Pharmaceutical composition
BRPI0610156A2 (pt) forma micronizada de um composto, forma purificada i do composto, kit, padrão de referência, e, método de preparaçao de uma composição farmacêutica.
GB0404420D0 (en) Pharmaceutical composition
BRPI0611748A2 (pt) composto, composição farmacêutica, e, uso de uma composição farmacêutica
ZA200701932B (en) Pharmaceutical composition
BRPI0614413A2 (pt) composto, e, composição farmacêutica
ITMI20041447A1 (it) Composizione farmaceutica comprendente gabapentina
ITMI20051826A1 (it) Kit per la somministrazione parenterale di medicamenti
BRPI0614412A2 (pt) composto, e, composição farmacêutica
ZA200701931B (en) Pharmaceutical composition
SI1906926T1 (sl) Farmacevtski sestavek, ki obsega 2,3-dihidro-6-nitroimidazo(2,1-b)oksazolne derivate
ZA200805656B (en) Prodrug ER²-selective substances, methods for the production thereof and pharmaceutical compositions containing said compounds
EP1850829A4 (en) NEW PROPOLFOL COMPOSITION WITH ASCORBIC ACID OR PHARMACEUTICALLY USEFUL SALTS
BRPI0610782A2 (pt) composto (-) -halofenato, composição farmacêutica, métodos para produzir um composto, para enriquecer enantiomericante um composto, para evitar ou tratar uma condição, e para a preparação de uma composição farmacêutica, e, composição
GB0402799D0 (en) Pharmaceutical composition

Legal Events

Date Code Title Description
B06G Technical and formal requirements: other requirements [chapter 6.7 patent gazette]

Free format text: SOLICITA-SE A REGULARIZACAO DA PROCURACAO, UMA VEZ QUE BASEADO NO ARTIGO 216 1O DA LPI, O DOCUMENTO DE PROCURACAO DEVE SER APRESENTADO NO ORIGINAL, TRASLADO OU FOTOCOPIA AUTENTICADA.

B15G Petition not considered as such [chapter 15.7 patent gazette]

Free format text: NAO CONHECIDA A PETICAO NO 020120000702/RJ DE 05/01/2012 EM VIRTUDE DO DISPOSTO NO ART. 219, INCISO II DA LPI.

B12F Other appeals [chapter 12.6 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 10A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2384 DE 13-09-2016 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.

B25E Requested change of name of applicant rejected

Owner name: WYETH (US)

B350 Update of information on the portal [chapter 15.35 patent gazette]